What: A woman received an astronomical bill for a routine IUD insertion due to a grandfathered insurance plan that doesn’t cover contraceptives.
Key line: “Fourteen thousand dollars is astronomical…”
Source: KFF Health News.
DOJ says states can’t overrule FDA—even as future restrictions loom.
Study finds no mass OBGYN flight from states with abortion bans—yet.
NPR adds more detail to WHI’s shutdown and the loss of 1990s-era women’s health data.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”
Cardiology experts warn cutting WHI would jeopardize sex-specific research advances.
Hormone therapy may lower a genetic heart risk factor, new WHI data suggests.
Women with endometriosis are more likely to face earlier surgical or natural menopause.
SWHR warns proposed Trump budget would slash NIH and CDC funding.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
Systemic hormones may worsen incontinence; local therapy helps, study says.
Healthier childhood diets—not body size—linked to later menstruation.
New data shows fertilizing 7–9 eggs is ideal for live births and minimizing excess embryos.
Pulitzer-winning series exposes the deadly impact of abortion bans.
New GLP-1 pill for diabetes patients shows 7%+ weight loss, boosting Eli Lilly stock.
Survey shows vast majority of women feel unprepared for menopause.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
An editorial calls for moving beyond reproductive-only focus in women’s health.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”
A small increase in births among women in their 30s and 40s offsets younger declines.